These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8770627

  • 1. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [Abstract] [Full Text] [Related]

  • 2. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C, Golia F, Vignali E, Pinchera A.
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [Abstract] [Full Text] [Related]

  • 3. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B, Puavilai G, Rajatanavin R.
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ.
    Eur J Med Res; 2005 Nov 16; 10(11):480-8. PubMed ID: 16354602
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
    De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P.
    Clin Endocrinol (Oxf); 1997 Nov 16; 47(5):529-35. PubMed ID: 9425392
    [Abstract] [Full Text] [Related]

  • 6. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M.
    Horm Res; 2005 Nov 16; 64(6):293-8. PubMed ID: 16269872
    [Abstract] [Full Text] [Related]

  • 7. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.
    Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA.
    Curr Med Res Opin; 2006 Jul 16; 22(7):1369-73. PubMed ID: 16834835
    [Abstract] [Full Text] [Related]

  • 8. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A.
    J Clin Endocrinol Metab; 1994 Apr 16; 78(4):818-23. PubMed ID: 8157704
    [Abstract] [Full Text] [Related]

  • 9. [Bone mineral density in patients on long-term therapy with levothyroxine].
    Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B.
    Lijec Vjesn; 1998 May 16; 120(5):103-5. PubMed ID: 9748785
    [Abstract] [Full Text] [Related]

  • 10. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S, Karner I.
    Medscape Womens Health; 2001 Oct 16; 6(5):3. PubMed ID: 11698925
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar 16; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L, Payer J, Killinger Z, Hruzikova P, Cierny D, Susienkova K, Langer P.
    Endocr Regul; 2010 Apr 16; 44(2):57-63. PubMed ID: 20429634
    [Abstract] [Full Text] [Related]

  • 13. [The influence of treatment with substitutive or suppressive doses of thyroxine on biochemical bone turnover markers].
    Kosińska A, Syrenicz A, Syrenicz M, Kosiński B, Miazgowski T, Garanty-Bogacka B.
    Ann Acad Med Stetin; 2005 Apr 16; 51(2):97-104. PubMed ID: 16519102
    [Abstract] [Full Text] [Related]

  • 14. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A, Singh MM, Mishra G, Singh BP, Jain GK, Jadhav S.
    Menopause; 2012 Jun 16; 19(6):642-9. PubMed ID: 22240638
    [Abstract] [Full Text] [Related]

  • 15. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.
    Jódar E, Begoña López M, García L, Rigopoulou D, Martínez G, Hawkins F.
    Osteoporos Int; 1998 Jun 16; 8(4):311-6. PubMed ID: 10024900
    [Abstract] [Full Text] [Related]

  • 16. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
    La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE.
    Minerva Ginecol; 2008 Dec 16; 60(6):475-84. PubMed ID: 18981975
    [Abstract] [Full Text] [Related]

  • 17. [The risk factors and bone mineral density in women on long-term levothyroxine treatment].
    López Alvarez MB, Hawkins F, Rigopoulou D, Martínez G, Jodar E, Estenoz J, Ortuño B, Arnaiz F.
    Med Clin (Barc); 1999 Jan 30; 112(3):85-9. PubMed ID: 10074614
    [Abstract] [Full Text] [Related]

  • 18. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 30; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY, Weetman AP, Eastell R.
    Clin Endocrinol (Oxf); 1997 Mar 30; 46(3):301-7. PubMed ID: 9156039
    [Abstract] [Full Text] [Related]

  • 20. Endocrine and physical determinants of bone mass in late postmenopause.
    Albanese CV, Civitelli R, Tibollo FG, Masciangelo R, Mango D.
    Exp Clin Endocrinol Diabetes; 1996 Mar 30; 104(3):263-70. PubMed ID: 8817245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.